MOLECULAR PARTNERS ADS/1 (6ML0) — Capital Reinvestment Ratio
Latest as of December 2022:
0.01x
MOLECULAR PARTNERS ADS/1 (6ML0) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow (€118.57 Million) in capital expenditures (€1.42 Million). See 6ML0 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
€118.57 Million
EUR
Capital Expenditures
€1.42 Million
EUR
Data as of
Dec 2022
Most recent filing
MOLECULAR PARTNERS ADS/1 Capital Reinvestment Ratio (2022–2022)
This chart tracks MOLECULAR PARTNERS ADS/1's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for MOLECULAR PARTNERS ADS/1 (2022–2022)
Year-by-year Capital Reinvestment Ratio for MOLECULAR PARTNERS ADS/1 from 2022 to 2022. For live market cap and broader valuation context, see how much is MOLECULAR PARTNERS ADS/1 worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.01x | €118.57 Million | €1.42 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow